Parabilis Medicines, Inc. Common Stock (PBLS) — Cash Flow-to-Debt Ratio
Parabilis Medicines, Inc. Common Stock (PBLS) has a Cash Flow-to-Debt Ratio of -0.35x as of March 2026, meaning its operating cash flow of $-49.20 Million could theoretically repay 0% of its total liabilities ($139.95 Million) in one year. Explore cash efficiency ratio of Parabilis Medicines, Inc. Common Stock to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Parabilis Medicines, Inc. Common Stock Cash Flow-to-Debt Ratio (2024–2025)
Historical debt coverage capacity for Parabilis Medicines, Inc. Common Stock across 2 annual periods. Also explore PBLS current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Parabilis Medicines, Inc. Common Stock (2024–2025)
Year-by-year debt coverage analysis for Parabilis Medicines, Inc. Common Stock. For market capitalisation and broader financial context, see Parabilis Medicines, Inc. Common Stock market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.27x | $-123.71 Million | $97.34 Million | ▼ -13.8% |
| 2024 | -1.12x | $-103.61 Million | $92.81 Million | — |